Viking Therapeutics
VKTX
#3884
Rank
NZ$6.01 B
Marketcap
NZ$47.19
Share price
-0.27%
Change (1 day)
-29.28%
Change (1 year)

EPS for Viking Therapeutics (VKTX)

EPS in 2026 (TTM): NZ-$9.45

According to Viking Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$9.76. In 2025 the company made an earnings per share (EPS) of NZ-$5.75 a decrease over its 2024 EPS that were of NZ-$1.81.

EPS history for Viking Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$9.4564.4%
2025NZ-$5.75218%
2024NZ-$1.81
2022NZ-$1.6526.39%
2021NZ-$1.3033.33%
2020NZ-$0.98
2018NZ-$0.71-51.25%
2017NZ-$1.45-20%
2016NZ-$1.81-64.08%
2015NZ-$5.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ-$9.38-3.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ-$0.36-96.30%๐Ÿ‡บ๐Ÿ‡ธ USA